Temporal pattern of gene expression and histology of stress fracture healing

Bone

Volumn 46, Issue 2, 2010, Pages 369-378

  Kidd, L J ^a   Stephens, A S ^b   Kuliwaba, J S ^c   Fazzalari, N L ^c   Wu, A C K ^a   Forwood, M R ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

^c HANSON INSTITUTE   (Australia)

Author keywords

Bone remodelling; Cytokines; Gene expression; Microdamage; Stress fracture

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CYCLOOXYGENASE 1; INTERLEUKIN 11; INTERLEUKIN 6; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROTEIN BCL 2; SCLEROSTIN; SOMATOMEDIN C; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE REMODELING; CONTROLLED STUDY; FEMALE; FRACTURE HEALING; GENE EXPRESSION; HISTOLOGY; MORPHOMETRICS; NONHUMAN; POLYMERASE CHAIN REACTION; RAT; SIGNAL TRANSDUCTION; STRESS FRACTURE; ULNA FRACTURE; UPREGULATION;

ACID PHOSPHATASE; ANIMALS; FEMALE; FRACTURE HEALING; FRACTURES, STRESS; GENE EXPRESSION REGULATION; ISOENZYMES; RATS; RATS, WISTAR; RNA, MESSENGER; TIME FACTORS; ULNA FRACTURES;

EID: 74249108001     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2009.10.009     Document Type: Article

References (69)

1. Burr D.B., Forwood M.R., Fyhrie D.P., Martin R.B., Schaffler M.B., and Turner C.H. Bone microdamage and skeletal fragility in osteoporotic and stress fractures. J. Bone Miner. Res. 12 (1997) 6-15
2. Muir P., Johnson K.A., and Ruaux-Mason C.P. In vivo matrix microdamage in a naturally occurring canine fatigue fracture. Bone 25 (1999) 571-576
3. Iwamoto J., and Takeda T. Stress fractures in athletes: review of 196 cases. J. Orthop. Sci. 8 (2003) 273-278
4. Riggs C.M. Fractures-a preventable hazard of racing thoroughbreds?. Vet. J. 163 (2002) 19-29
5. Schaffler M.B. Incidence and prevalence of stress fractures in military and athletic populations. In: Burr D.B., and Milgrom C. (Eds). Musculoskeletal Fatigue and Stress Fractures (2001)
6. Young A.J., and McAllister D.R. Evaluation and treatment of tibial stress fractures. Clin. Sports. Med. 25 (2006) 117-128
7. Tsangari H., Findlay D.M., Zannettino A.C., Pan B., Kuliwaba J.S., and Fazzalari N.L. Evidence for reduced bone formation surface relative to bone resorption surface in female femoral fragility fracture patients. Bone 39 (2006) 1226-1235
8. Mori S., Li J., and Kawaguchi H. The histological appearance of stress fractures. In: Burr D.B., and Milgrom C. (Eds). Musculoskeletal Fatigue and Stress Fractures (2001), CRC Press 151-160
9. Einhorn T.A. The cell and molecular biology of fracture healing. Clin. Orthop. Relat. Res. (1998) S7-21
10. McKibbin B. The biology of fracture healing in long bones. J. Bone Joint. Surg. Br. 60-B (1978) 150-162
11. Stover S.M., Johnson B.J., Daft B.M., Read D.H., Anderson M., Barr B.C., et al. An association between complete and incomplete stress fractures of the humerus in racehorses. Equine. Vet. J. 24 (1992) 260-263
12. Hasselman C.T., and Gruen G.S. Principles of operative fracture stabilization and fixation. In: Fitzgerald R.H., Kaufer H., and Malkani A.L. (Eds). Orthopaedics (2002), Mosby 228-238
13. Peris P. Stress fractures. Best. Pract. Res. Clin. Rheumatol. 17 (2003) 1043-1061
14. Rolf C., Ekenman I., Tornqvist H., and Gad A. The anterior stress fracture of the tibia: an atrophic pseudoarthosis?. Scand. J. Med. Sci. Sports. 7 (1997) 249-252
15. Bentolila V., Boyce T.M., Fyhrie D.P., Drumb R., Skerry T.M., and Schaffler M.B. Intracortical remodeling in adult rat long bones after fatigue loading. Bone 23 (1998) 275-281
16. Danova N.A., Colopy S.A., Radtke C.L., Kalscheur V.L., Markel M.D., Vanderby R., et al. Degradation of bone structural properties by accumulation and coalescence of microcracks. Bone 33 (2003) 197-205
17. Muir P., Sample S.J., Barrett J.G., McCarthy J., Vanderby Jr. R., Markel M.D., et al. Effect of fatigue loading and associated matrix microdamage on bone blood flow and interstitial fluid flow. Bone 40 (2007) 948-956
18. Uthgenannt B.A., and Silva M.J. Use of the rat forelimb compression model to create discrete levels of bone damage in vivo. J. Biomech. 40 (2007) 317-324
19. Hsieh Y.F., and Silva M.J. In vivo fatigue loading of the rat ulna induces both bone formation and resorption and leads to time-related changes in bone mechanical properties and density. J. Orthop. Res. 20 (2002) 764-771
20. Tami A.E., Nasser P., Schaffler M.B., and Knothe Tate M.L. Noninvasive fatigue fracture model of the rat ulna. J. Orthop. Res. 21 (2003) 1018-1024
21. Li J., Waugh L.J., Hui S.L., Burr D.B., and Warden S.J. Low-intensity pulsed ultrasound and nonsteroidal anti-inflammatory drugs have opposing effects during stress fracture repair. J. Orthop. Res. 25 (2007) 1559-1567
22. Kuroda S., Virdi A.S., Dai Y., Shott S., and Sumner D.R. Patterns and localization of gene expression during intramembranous bone regeneration in the rat femoral marrow ablation model. Calcif. Tissue Int. 77 (2005) 212-225
23. Meyer R.A., Meyer M.H., Phieffer L.S., and Banks D.M. Delayed union of femoral fractures in older rats: decreased gene expression. BMC Musculoskelet. Disord. 2 (2001) 2
24. Einhorn T.A., Majeska R.J., Rush E.B., Levine P.M., and Horowitz M.C. The expression of cytokine activity by fracture callus. J. Bone Miner. Res. 10 (1995) 1272-1281
25. Mori S., and Burr D.B. Increased intracortical remodeling following fatigue damage. Bone 14 (1993) 103-109
26. Colopy S.A., Benz-Dean J., Barrett J.G., Sample S.J., Lu Y., Danova N.A., et al. Response of the osteocyte syncytium adjacent to and distant from linear microcracks during adaptation to cyclic fatigue loading. Bone 35 (2004) 881-891
27. Noble B.S., Peet N., Stevens H.Y., Brabbs A., Mosley J.R., Reilly G.C., et al. Mechanical loading: biphasic osteocyte survival and targeting of osteoclasts for bone destruction in rat cortical Bone. Am. J. Physiol. Cell Physiol. 284 (2003) C934-43
28. Noble B.S., Stevens H., Loveridge N., and Reeve J. Identification of apoptotic changes in osteocytes in normal and pathological human Bone. Bone 20 (1997) 273-282
29. Verborgt O., Tatton N.A., Majeska R.J., and Schaffler M.B. Spatial distribution of Bax and Bcl-2 in osteocytes after bone fatigue: complementary roles in bone remodeling regulation?. J. Bone Miner. Res. 17 (2002) 907-914
30. Verborgt O., Gibson G.J., and Schaffler M.B. Loss of osteocyte integrity in association with microdamage and bone remodeling after fatigue in vivo. J. Bone Miner. Res. 15 (2000) 60-67
31. Fazzalari N.L., Kuliwaba J.S., Atkins G.J., Forwood M.R., and Findlay D.M. The ratio of messenger RNA levels of receptor activator of nuclear factor kappaB ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritis. J. Bone Miner. Res. 16 (2001) 1015-1027
32. Forwood M.R., Bennett M.B., Blowers A.R., and Nadorfi R.L. Modification of the in vivo four-point loading model for studying mechanically induced bone adaptation. Bone 23 (1998) 307-310
33. Perren S.M., Huggler A., Russenberger M., Allgower M., Mathys R., Schenk R., et al. The reaction of cortical bone to compression. Acta Orthop. Scand. Suppl. 125 (1969) 19-29
34. Olerud S., and Danckwardt-Lilliestrom G. Fracture healing in compression osteosynthesis in the dog. J. Bone Joint. Surg. Br. 50 (1968) 844-851
35. Hofbauer L.C., and Heufelder A.E. Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology. J. Mol. Med. 79 (2001) 243-253
36. Abdallah B.M., Stilgren L.S., Nissen N., Kassem M., Jorgensen H.R., and Abrahamsen B. Increased RANKL/OPG mRNA ratio in iliac bone biopsies from women with hip fractures. Calcif. Tissue. Int. 76 (2005) 90-97
37. Li L., Pettit A.R., Gregory L.S., and Forwood M.R. Regulation of bone biology by prostaglandin endoperoxide H synthases (PGHS): a rose by any other name. Cytokine Growth Factor Rev. 17 (2006) 203-216
38. Forwood M.R. Inducible cyclo-oxygenase (COX-2) mediates the induction of bone formation by mechanical loading in vivo. J. Bone Miner. Res. 11 (1996) 1688-1693
39. Pilbeam C.C., Kawaguchi H., Hakeda Y., Voznesensky O., Alander C.B., and Raisz L.G. Differential regulation of inducible and constitutive prostaglandin endoperoxide synthase in osteoblastic MC3T3-E1 cells. J. Biol. Chem. 268 (1993) 25643-25649
40. Heymann D., and Rousselle A.V. gp130 Cytokine family and bone cells. Cytokine 12 (2000) 1455-1468
41. Kudo O., Sabokbar A., Pocock A., Itonaga I., Fujikawa Y., and Athanasou N.A. Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism. Bone 32 (2003) 1-7
42. Sims N.A., Jenkins B.J., Nakamura A., Quinn J.M., Li R., Gillespie M.T., et al. Interleukin-11 receptor signaling is required for normal bone remodeling. J. Bone Miner. Res. 20 (2005) 1093-1102
43. Palmqvist P., Persson E., Conaway H.H., and Lerner U.H. IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae. J. Immunol. 169 (2002) 3353-3362
44. Tsangari H., Findlay D.M., Kuliwaba J.S., Atkins G.J., and Fazzalari N.L. Increased expression of IL-6 and RANK mRNA in human trabecular bone from fragility fracture of the femoral neck. Bone 35 (2004) 334-342
45. Rozen N., Lewinson D., Bick T., Jacob Z.C., Stein H., and Soudry M. Fracture repair: modulation of fracture-callus and mechanical properties by sequential application of IL-6 following PTH 1-34 or PTH 28-48. Bone 41 (2007) 437-445
46. Suga K., Saitoh M., Fukushima S., Takahashi K., Nara H., Yasuda S., et al. Interleukin-11 induces osteoblast differentiation and acts synergistically with bone morphogenetic protein-2 in C3H10T1/2 cells. J. Interferon. Cytokine. Res. 21 (2001) 695-707
47. Suga K., Saitoh M., Kokubo S., Fukushima S., Kaku S., Yasuda S., et al. Interleukin-11 acts synergistically with bone morphogenetic protein-2 to accelerate bone formation in a rat ectopic model. J. Interferon. Cytokine. Res. 23 (2003) 203-207
48. Suga K., Saitoh M., Kokubo S., Nozaki K., Fukushima S., Yasuda S., et al. Synergism between interleukin-11 and bone morphogenetic protein-2 in the healing of segmental bone defects in a rabbit model. J. Interferon. Cytokine. Res. 24 (2004) 343-349
49. Takeuchi Y., Watanabe S., Ishii G., Takeda S., Nakayama K., Fukumoto S., et al. Interleukin-11 as a stimulatory factor for bone formation prevents bone loss with advancing age in mice. J. Biol. Chem. 277 (2002) 49011-49018
50. Thi M.M., Iacobas D.A., Iacobas S., and Spray D.C. Fluid shear stress upregulates vascular endothelial growth factor gene expression in osteoblasts. Ann. N. Y. Acad. Sci. 1117 (2007) 73-81
51. Cillo Jr. J.E., Gassner R., Koepsel R.R., and Buckley M.J. Growth factor and cytokine gene expression in mechanically strained human osteoblast-like cells: implications for distraction osteogenesis. Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod. 90 (2000) 147-154
52. Koyama Y., Mitsui N., Suzuki N., Yanagisawa M., Sanuki R., Isokawa K., et al. Effect of compressive force on the expression of inflammatory cytokines and their receptors in osteoblastic Saos-2 cells. Arch. Oral. Biol. (2008)
53. Wadhwa S., Choudhary S., Voznesensky M., Epstein M., Raisz L., and Pilbeam C. Fluid flow induces COX-2 expression in MC3T3-E1 osteoblasts via a PKA signaling pathway. Biochem. Biophys. Res. Commun. 297 (2002) 46-51
54. Singh S.P., Chang E.I., Gossain A.K., Mehara B.J., Galiano R.D., Jensen J., et al. Cyclic mechanical strain increases production of regulators of bone healing in cultured murine osteoblasts. J. Am. Coll. Surg. 204 (2007) 426-434
55. Frost H.M. The regional acceleratory phenomenon: a review. Henry. Ford. Hosp. Med. J. 31 (1983) 3-9
56. Rohde C., Anderson D.E., Bertone A.L., and Weisbrode S.E. Effects of phenylbutazone on bone activity and formation in horses. Am. J. Vet. Res. 61 (2000) 537-543
57. Schilling T., Muller M., Minne H.W., and Ziegler R. Influence of inflammation-mediated osteopenia on the regional acceleratory phenomenon and the systemic acceleratory phenomenon during healing of a bone defect in the rat. Calcif. Tissue Int. 63 (1998) 160-166
58. Mueller M., Schilling T., Minne H.W., and Ziegler R. A systemic acceleratory phenomenon (SAP) accompanies the regional acceleratory phenomenon (RAP) during healing of a bone defect in the rat. J. Bone Miner. Res. 6 (1991) 401-410
59. Sample S.J., Behan M., Smith L., Oldenhoff W.E., Markel M., Kalscheur V.L., et al. Functional adaptation to loading of a single bone is neuronally regulated and involves multiple bones. J. Bone Miner. Res. 23 (2008) 1372-1381
60. Brandi M.L., and Collin-Osdoby P. Vascular biology and the skeleton. J. Bone Miner. Res. 21 (2006) 183-192
61. 18F-fluoride with positron emission tomography reveals damage- and time-dependent responses to fatigue loading in the rat ulna. Bone 39 (2006) 229-236
62. Matsuzaki H., Wohl G.R., Novack D.V., Lynch J.A., and Silva M.J. Damaging fatigue loading stimulates increases in periosteal vascularity at sites of bone formation in the rat ulna. Calcif. Tissue. Int. 80 (2007) 391-399
63. Wohl G.R., Towler D.A., and Silva M.J. Stress fracture healing: fatigue loading of the rat ulna induces upregulation in expression of osteogenic and angiogenic genes that mimic the intramembranous portion of fracture repair. Bone 44 (2009) 320-330
64. 3 on osteoblasts are enhanced by vascular endothelial growth factor produced by osteoblasts and by growth factors produced by endothelial cells. Endocrinology 138 (1997) 2953-2962
65. Gronthos S., and Zannettino A.C. The role of the chemokine CXCL12 in osteoclastogenesis. Trends Endocrinol. Metab. 18 (2007) 108-113
66. Wright L.M., Maloney W., Yu X., Kindle L., Collin-Osdoby P., and Osdoby P. Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts. Bone 36 (2005) 840-853
67. Duvall C.L., Taylor W.R., Weiss D., Wojtowicz A.M., and Guldberg R.E. Impaired angiogenesis, early callus formation, and late stage remodeling in fracture healing of osteopontin-deficient mice. J. Bone Miner. Res. 22 (2007) 286-297
68. Chellaiah M.A., Kizer N., Biswas R., Alvarez U., Strauss-Schoenberger J., Rifas L., et al. Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression. Mol. Biol. Cell. 14 (2003) 173-189
69. Noble B. Microdamage and apoptosis. Eur. J. Morphol. 42 (2005) 91-98